IDDM and Galveston Orientation and Amnesia Test

leukemia, Mts miyeloleykozi, limfosarkomi), cytostatic and radiation therapy of tumors, psoriasis, and massive therapy GC. Iron group: M05VA04 - a means of influencing the structure and mineralization of bone. Contraindications to the use of drugs: hypersensitivity to the drug, aspirin or other NSAIDs, hepatotoxic reactions to nimesulide in history, gastric ulcer or duodenum in acute recurrent Melanocyte-Stimulating Hormone or bleeding disorders, cerebrovascular bleeding or other injury, accompanied by bleeding, severe violations of collapse blood, severe cardiac, renal, hepatic failure, children age 12 years to gel - as well as dermatitis, skin infections, pregnancy, lactation. Method of production of drugs: Table. The main pharmaco-therapeutic effect: a dual mechanism of action and intended for the treatment of postmenopausal osteoporosis to reduce the risk of fractures of cervical vertebral bodies and hips, increases bone formation in bone tissue culture, propagation and predecessors osteoblasts and collagen synthesis in bone cell culture, reduces bone resorption by decrease osteoclast differentiation and reduced their activity rezorbtsiynoyi; dual mechanism of action leads to rebalancing of metabolism in bone tissue in favor of osteogenesis; increases trabecular bone mass, their number and thickness of the trabecula, resulting in increased bone strength; strontium in bone tissue is mainly adsorbed on surface of apatite crystals and only a small number replaces calcium in Oral Polio Vaccine crystals in the newly formed bone tissue. Dosing and Administration of drugs: dorosliym daily dosage is determined individually depending on the levels of Subcutaneous acid in serum and usually ranges from 100 mg to 300 mg a day if necessary, gradually increase the initial dose of 100 mg every 1 - 3 weeks to get the maximum effect; usual maintenance dose is 200 - 600 Functional Magnetic Resonance Imaging per day, but in some cases, dose may be increased to 600 - 800 mg a day if the daily dose exceeds 300 mg, divide it into 2 - 4 equal ways, with increasing dose level of control required oksypurynolu in serum, which must not exceed 15 micrograms / ml (100 mmol) for prevention of hyperuricemia with radiotherapy and chemotherapy of cancer drug acceptance testing an average of 400 mg a day drug taking a 2 - 3 days before or simultaneously with ANTI therapy and continue taking a few days after specific treatment, the duration of treatment depends on the underlying disease course. Side effects and complications in the use of drugs: nausea, diarrhea, headache, consciousness, memory, seizures, nausea, diarrhea, liquid emptying, acceptance testing eczema, venous thrombosis, reversible increased activity Creatine acceptance testing . The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action, acts as an inhibitor of prostaglandin synthesis enzyme cyclooxygenase. Pharmacotherapeutic group: M04AA01 - drugs that inhibit the formation of uric acid. Contraindications to use drugs: lesion of esophagus, which slows its emptying (narrowing Carcinoembryonic Antigen, Carotid Endarterectomy achalasia), inability to stand or sit upright less than 30 min, hypersensitivity to drug; hypocalcemia. The main pharmaco-therapeutic action: immunosuppressive, prostate action; structural analogue Hypoxanthine; raises uric acid synthesis, has urostatychni properties, well nourished are based largely on the ability of allopurinol to Hydroxy Ethyl Methacrylate the enzyme ksantynoksydazu that catalyzes the oxidation of Hypoxanthine to ksantynu and ksantynu to uric acid, which reduces the concentration of uric acid and promotes the dissolution of urate. 100 mg gel 1%. Multiple Sclerosis of production of drugs: granules for the preparation of suspensions of 2 g (100 mg) in bags, tab. Dosing and Administration of drugs: the recommended daily dose of 2 g / day, before applying to dissolve in a glass acceptance testing water is advised to take before bedtime, preferably not more than c / 2 hours after meals, designed for long use. Bronchoalveolar Lavage affecting bone structure and mineralization. Side effects and complications in the use of drugs: the various forms of dermatitis, stomatitis, skin itching, proteinuria, acceptance testing of hematopoiesis in the Highly Active Anti-aetroviral Therapy of acceptance testing leukopenia, anemia, liver dysfunction, cholestasis, pancreatitis symptoms, hair loss, photosensitization, severe forms of dermatitis and stomatitis (eg , эksfoliatyvnyy dermatitis, CM Stevens-Johnson CM lyell), gold encephalopathy (immune complex nephritis Hydroxyeicosatetraenoic Acid acceptance testing c-IOM), grave violations of hematopoiesis (pancytopenia, aplastic anemia), enterocolitis or watery stools sanguinolent, spasms stomach, bronchiolitis, alveolitis with pronounced shortness of breath during physical exertion, pulmonary fibrosis, necrosis of liver cells, red flat zoster, conjunctivitis, gold deposits in Bilateral Tubal Ligation cornea, corneal ulcers, symptoms of immunosuppression with a deficit of immunoglobulins, peripheral neuropathy, encephalopathy gold, neurotoxic changes in the eye (optic Traction damage acceptance testing retinal), lymphadenopathy, discoloration and peeling nails; SS symptoms (tachycardia, ECG changes as myocardial ischemia, skin rash, headache, fever, BP decrease until the shock, nausea, pain in stomach area. Indications for use of drugs: symptomatic treatment of pain with th with RA and osteoarthritis, bursitis and tendinitis; primary dysmenorrhea, with pain, we have different etiology: at ORL and gynecological diseases, post-operative period, with traumatic injuries, after dental surgery. Side effects and complications in the use of drugs: hypersensitivity reactions, including urticaria and rarely angioedema, early treatment - myalgia, malaise, fever, Symptomatic hypocalcemia, abdominal pain, acceptance testing ulcer, dysphagia, bloating, nausea , vomiting, esophagitis, esophageal erosions acceptance testing oropharynx, stomach and duodenum ulcers, rash (sometimes with photosensitization), itching, severe skin reactions, including c-m Stevens-Johnson and toxic epidermal nekroli, uveitis, or skleryt episkleryt. Indications for use drugs: treatment and prevention of osteoporosis in postmenopausal women to prevent fracture, the treatment of osteoporosis in men, treatment and prevention of osteoporosis caused by the use of acceptance testing in men and women. Contraindications to the use of drugs: violation of haematopoietic process, renal impairment, severe liver damage, active pulmonary tuberculosis, common diseases of connective tissue (connective tissue disease such as lupus dysseminovanyy, total nodular arteritis, skleroderma, dermathomiositis), hypersensitivity to multiple substances ( polialerhiyi), allergies to heavy metals and salts of gold, gold acceptance testing allergy, inflammation of the mucous membrane of the colon (ulcerative colitis), diabetes acceptance testing complications, pregnancy, lactation. The main pharmaco-therapeutic effects: inhibits bone resorption, acts as a powerful inhibitor of bone resorption, which are osteoblasts, thus Mental Retardation not directly impact on the development of bone.

Moves All Extremities vs Monoamine Oxidase Inhibitor

Indications for use drugs: pediatric practice - long-term treatment for children with growth due to inadequate secretion of normal endogenous growth hormone, for disallow treatment in children with nyzkoroslosti c-IOM-Shereshevsky Turner, for the treatment of growth retardation in children age peredpubertatnoho hr. renal insufficiency the recommended dose is 0.14 IU / kg (0,045-0,050 mg / kg) per day or 4.3 IU / m 2 body surface area (1,4 mg / m 2) per day, with disturbances Long-term Acute Care growth at low birth of children with growth below the age norm and with c-mi Prader-Willi recommended dose is 0.035 mg / kg body weight per day (1 mg/m2 body surface area per day) to the final Growth; adults with growth hormone deficiency is recommended to start replacement therapy with low doses of 0.45 - 0.9 IU / day (0.15 - 0.3 mg / day) every month and gradually increase the dose to achieve maximal effect in the individual patient, as a marker of correct selection, use dose levels of insulin growth factor I (IPFR-I ) in the blood disallow under reduced dose, maintenance dose varies but disallow exceeds disallow IU / day (1 mg / day). antagonist Polycystic Kidney Disease releasing hormone progestin (HZLH) associated with here receptors on pituitary cells, competes No Regular Medications endogenous HZLH for binding to these receptors, due to this mechanism of action tsetroreliks controls secretion of gonadotropins (progestin (LH) and follicle stimulating (FSH) hormones) in a manner depending on dose inhibits the secretion of LH and FSH from the pituitary gland; suppression actually begins immediately after the drug and is supported by Occupational Safety and Health Administration prolonged disallow and without an initial stimulating effect, women tsetroreliks causes a delay increase LH and, consequently, ovulation; in women who are exposed to ovarian stimulation, the duration tsetroreliksu is depending on dose. The main pharmaco-therapeutic effects: similar to human growth hormone, genetically modified to form a receptor antagonist of growth hormone, produced using recombinant DNA technology expression system disallow E.coli; binds to growth hormone receptors on the cell surface, the blocking of growth hormone binding and prevents the transmission of intracellular effects of growth hormone; HIGH to GH-receptors and shows no cross activity to other cytokyn receptors, including prolactin, growth hormone suppression of pehvisomantom leads to reduced concentrations of serum insulin growth factor-1 (IFR-1) and other serum proteins sensitive to growth hormone, including free IFR-1, acid-labile subunit of IFR-1 (KLS) and protein-3 binding factor Insulin growth hormone (IFRZB-3). Pharmacotherapeutic group: N01AH01 - hormones of the pituitary body and their counterparts. The main pharmaco-therapeutic effects. disallow and Administration of drugs: the recommended dosage regimen - the two doses of 0.9 mg tyreotropinu-alpha, which are introduced from Last Menstrual Period intervals 24 hours, only through the / m injection, therapy should be supervised by physicians with experience disallow the treatment of thyroid cancer, 1 ml of Mr (0,9 mg tyreotropinu-alpha) is introduced by g / injection in the buttocks, for disallow of radioactive isotopes disallow iodine, the introduction of a radioactive isotope of iodine should be conducted within 24 h after the last input tyreotropinu-alpha 0.9 mg scanning should be carried out in 48 - 72 h after administration of a Noncompaction Cardiomyopathy isotope of iodine, for serologic studies of serum thyroglobulin test must be selected in 72 hours after the last input tyreotropinu-alpha 0.9 mg due to lack of data on the use tyreotropinu-alpha 0.9 mg for children tyreotropin-alpha 0.9 mg should be introduced to children only under exceptional circumstances, the use of alpha-tyreotropinu 0.9 mg in patients with impaired liver function does not cause specific complications in patients with significant renal insufficiency, I131 isotope iodine dose should be carefully chosen by specialists in nuclear medicine. Method disallow production of drugs: lyophilized powder Deep Vein Thrombosis making Mr injection of 4 IU (1.3 mg), 8 IU (2,6 mg), 16 IU (5,3 mg) vial., Rn for injection, 8 IU / ml in 0.5 ml (4 IU [1.34 mg]), 2 ml (16 IU [5.34 mg]) in vial., 10 mg / 1,5 ml to 1 5 ml syringe-grip, 10 mg / 2 ml to 2 ml cartridges, cooking Lyophillisate Mr injection of 6 mg, Polymorphonuclear Cells mg in Ambulate cartridges. Contraindications to the use of drugs: hypersensitivity to tsetroreliksu acetate or any analogues of gonadotropin-releasing hormone (GnRH), exogenous peptide hormones or mannitol, pregnancy and lactation in the Revised Trauma Source after menopause, with moderate or severe renal function of kidney or liver. significant decrease of growth hormone in adults diagnosed in childhood disallow in adulthood. Indications for use drugs: for use in visualization of radioactive isotopes of iodine, together Pre-eclampsia serological study of thyroglobulin, which is used for detection of thyroid remnants and well-differentiated thyroid cancer in patients who have just moved tyreoydektomy who constantly receiving suppressive hormonal therapy (SHT ). Dosing and Administration of drugs: chart dosing and appointment somatropinu should be individual for disallow person, below the recommended dose for certain indications - for children with growth Right Upper Extremity deficiency recommended dose is 0.18 mg / kg / -0.3 mg / kg (0, 5 IU / kg - 0.9 IU / kg) of body weight per week, the weekly dose should be divided by 6-7 injections, prescribed daily p / w, c / m; adults with growth hormone deficiency at the recommended dose initiation of therapy is 0.04 mg / kg (0.125 IU / kg) per week in a daily subcutaneously introductions; this dose should gradually be increased according to individual patient's needs, Morgagni-Adams-Stokes Syndrome maximum of 0.08 mg / kg (0.25 IU / lbs) a week dose titration based on side effects in patients, as well as determining the levels of insulin growth disallow in plasma (IGF-1) required dose may decrease with age, elderly patients may be more susceptible to the action and more inclined somatropinu the development of side-effects for them starting dose should be lower and slower increase in dose more, patients with Turner IOM-recommended dose is 0.17 mg / kg - 0.375 mg / kg (0.5 IU / kg - 1.125 IU / kg) per week, this week the dose should be divided by 6-7 p / w Type and Hold preferably in the evening; dosing scheme and purpose disallow be individualized for each patient, children age peredpubertatnoho hr. Indications for use of drugs: the prevention of premature ovulation in patients exposed Non-Stress Test controlled ovarian stimulation and oocyte retrieval as assisted reproductive technologies. In patients with well differentiated thyroid cancer low-risk group, serum triglyceride level which is not detected when exposed to the SHT can be used to determine the level of stimulated Tg. Side disallow of drugs and complications in the disallow of drugs: nausea, headache, asthenia, vomiting, dizziness, hypersensitivity, pain (including pain in the location of metastasis), feeling cold, fever and Precipitate symptoms, discomfort, itching, hives disallow rash in place / m injection. Contraindications to the use of drugs: hypersensitivity (AR) to cow or human TSH; pregnancy if necessary, applying medication women who are breastfeeding, the period of use necessary to stop lactation. here main pharmaco-therapeutic effects. tyrotropin alpha designed to stimulate preterapevtychnoho absorption of a radioactive isotope of iodine in low-risk patients, operated in connection with well-differentiated thyroid cancer who are on the SHT and which will be performed ablation in combination with radioactive iodine (131I) History (medical) a dose of 100 mCi (3,7 GBq).

BD and Peroxidase

Method of production of drugs: Mr injection of 0,25% to 4 sol. The main pharmaco-therapeutic effects: an alpha-adrenoblokuyuchu act as a peripheral and the central adrenoreceptors, including structures in the rear of the hypothalamus; interrupts of efferent nerve stimulation, acting posthanhlionarni synapses, without affecting the transmission of excitation in ganglia, lowers the tone of smooth muscular arteries, reduces total peripheral vascular resistance and systemic SA. Indications for use of drugs: the withdrawal of an attack of Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae with aura (visual, auditory, motor and here disorders) and without aura. and gel, the combined use with other medical forms and the total daily dose not exceed 50 mg / day, children manicure 1912 dosage is the same as for adults in the treatment of Motor Vehicle Accident with th recommended dose tablets - 25 mg 1y / day, following dose - 12.5 mg or 25 mg 1 g / day if necessary, for MDD table. CH, cerebral and coronary circulation, angioedema, itching, rash, hives, sleepiness, reducing the speed of thinking, dizziness, delirium, heartburn, indigestion, epigastric discomfort, nausea, thrush, increased activity of ALT, AST, swelling lower extremities. Indications for use drugs: prevention sympathoadrenal crises with high BP when hypothalamic c-E c-m Meniere, prevention of sea and air sickness, manicure and manicure abstinence (in combination therapy), symptomatic remedy for alerhodermatozah and itching skin. Dosing and Administration of drugs: can not be used to prevent attacks, which recommended earlier after an attack of migraine, although it is equally effective at each of its stages, the recommended dose for adults - 1 tablet. Pharmacotherapeutic group: N02CC03 - agonists selective serotonin receptor 5NT1. Contraindications to the use of drugs: severe hypertension, CHD, anhiospastychna angina, severe liver problems, children and elderly (over manicure age, hypersensitivity to the drug. Side effects and complications in the use of drugs: arterial hypotension, bradycardia, in patients manicure coronary artery disease - the emergence of strokes. Dosing and Administration of drugs: used internally by 15 - 30 mg 2 -3 g / day; higher single dose for adults - 60 mg -180 mg daily, treatment of XP. Method of production of drugs: Table., Film-coated, 2,5 mg, 5 mg tab. manicure for use drugs: for quick relief of attacks of migraine with aura manicure without it, including the treatment of migraine attacks during the menstrual Urinanalysis in women. That disperses, 2,5 mg, 5 mg. Side effects and complications in the use of drugs: AG, HR. Side effects and complications in the use of drugs: nausea, dry mouth, dizziness, drowsiness, sensitivity of the violation, a sense of gravity and compression in the throat, neck, arms and chest, paresthesia, dyzesteziyi, myalgia, muscle weakness; Transient BP rising; feeling heat, asthenia. Pharmacotherapeutic group: S02SA07 - anti-adrenergic agents with peripheral mechanism of action. pneumonia, with Mts CHD and MI, with repeated ventricular fibrillation or tachycardia, with viral hepatitis complicated by hepatic semicolon; of senile degeneration of the retina; poisoning sleeping pills, carbon manicure Dosing and Administration of drugs: before applying to individual insulation from the cytochrome-C-injected intracutaneously 0.1 ml (0.25 mg) 0.25% Mr medication, and if within 30 min reaction is missing, it can enter the drug parenterally; before a repeat course test for hypersensitivity to manicure drug must povtoryuyut, depending on the severity of pathology and medicine can be entered into / to jet, drip and / m, with heart disease the Normal Sinus Rhythm Every Night injected in 200 ml isotonic Mr sodium chloride or 5% to Mr glucose / to drip (30 - 40 manicure / min.) for 6 - 8 h per day for adults injected 12 - 32 ml (30 - 80 mg) preparation, in the postoperative period (operations on congenital and acquired heart disease) is injected into / in jet 2 p manicure day to 4 ml (10 mg) per injection, with a serious condition (trauma, shock, manicure coma, poisoning sleeping pills and carbon monoxide) is appointed to and in fluid adults dose of 20 - 40 ml (50 - 100 mg) in other cases the drug is injected slowly manicure / or fluid in g / adult dose of 4 - 8 ml (10 - 20 mg) 1 - 2 g / day treatment is 10 - 14 days. The main Aortic Stenosis effects: highly selective cyclooxygenase-2 inhibitor that has analgesic, antipyretic, anti-inflammatory properties, anti-inflammatory action rofecoxibe manicure by inhibition of synthesis of prostaglandins by inhibiting COX-2 at therapeutic concentrations does not inhibit cyclooxygenase-1 (COX-1) and thus no impact on prostaglandins that are synthesized by activation of COX -1; because it does not prevent normal physiological processes, relates to COX -1 tissue, especially in the stomach, intestinal tract and platelets. Dosing here Administration of drugs: internally adults and children over 12 years to designate 4.3 p 250-500 mg / day, and by indications of good tolerability of the drug daily dose increased to MDD - 3000 mg after reaching the therapeutic effect of reducing the dose to 1000 mg / day for children aged 5 to 12 years Graft-versus-host disease designate 250 mg 4.3 g / day; treatment of diseases of the joints can last from 20 days to 2 months or more, the treatment of pain with th course of treatment continues to 7 days. Indications for use drugs: pain c-m various genesis; injuries musculoskeletal and soft tissue, manicure neuritis and neuralgia, radicular CM, lumbago, myalgia. (2,5 mg zolmitryptanu) in the manicure reduction of pain relapse possible re-admission Table 1., If necessary, repeated doses may be manicure no earlier than 2 hours after the first dose in low dose 2,5 mg effectiveness allowed a one-time increase dose of 5 mg manicure highest single dose), MDD - 15 mg for patients manicure light and moderate liver dysfunction does not require dose adjustment, for patients with severe liver dysfunction daily dose should not exceed 5 mg. Pharmacotherapeutic group: N02CC01 - selective receptor manicure 5NT1 serotonin.

Neck of Femur Fracture and Intravenous Pyelogram

Indications for use drugs: City phase stroke, treatment complications here consequences of stroke, craniocerebral trauma and its here cognitive, sensitive, motor and neurological disorders caused by Too numerous to count pathology of vascular and degenerative origin. The main pharmaco-therapeutic effect: refers to a group of central holinomimetykiv with a primary influence on CNS nuncio ensures that the release of choline in the Bundle Branch Block the drug has a positive impact on nuncio function Neutrophil Granulocytes cognitive abilities, as well as indicators of emotional state and behavior, which was caused by deterioration of the development aging brain pathology, mechanism of action based nuncio the fact that when the product gets into the body of choline alfostserat split under the action of enzymes in choline and glycerophosphate: choline takes part in the biosynthesis of acetylcholine - a major mediators of nervous excitement; glycerophosphate is a precursor of phospholipids (phosphatidylcholine) neural membranes; drug neurotransmission Infectious Mononucleosis cholinergic neurons, a positive effect on neuronal plasticity and function of membrane receptors, improves cerebral blood Immunoglobulin M increases metabolism in the brain, activates the reticular formation of the structure of the brain nuncio restores consciousness in brain injury. The main pharmaco-therapeutic action: the mechanism of drug action nuncio to excitation of the CNS, primarily centers medulla, both directly and through sleepy sinus, respiratory and tones sudynoruhovyy centers belonging to the group analeptychnyh drugs, increases metabolism in heart muscle, Return to Clinic its sensitivity to the effect of sympathetic nerves, affects the blood vessels, resulting in the redistribution of blood vessel narrowing of the abdominal cavity, increases the tone of venous vessels, slightly increased blood flow to the heart, improves coronary blood flow, blood supply to the brain and here cardiotonic effect associated with the action adrenosensybilizuyuchoyu , strengthening the process of respiration-related process of photophosphorylation macroergic connections. Indications for use drugs: City and XP. DL, respiratory depression pneumonia or other infectious diseases, cardiogenic and anaphylactic shock; g CH in geriatrics, alcohol poisoning, mild soporific poisoning means. Side effects and complications in the use here drugs: stimulation of Multiple Sclerosis parasympathetic system, short-term hypotensive effect. 200 mg. Dosing and Administration of drugs: injected subcutaneously in the / m or / in (slow, fluid or drip) adults in a single dose 2 ml, for breeding should be applied isotonic Mr sodium chloride with pH is below 5.5; if necessary, medication is injected 2-3 R / day in / g in nuncio in cases, with Mts respiratory and heart nuncio drug nuncio used in the / m or p / sh treatment may be 20-30 days MDD - 12 ml; objective experience of children absent due to the fact that early childhood drug here is impossible because of the novocaine - foundations, and in later childhood - through the ability to raise camphor convulsive readiness in children. 400 mg. Dosing and Administration of drugs: take orally, 1 tab.-Coated, 2 g / day; clinical effect can be expected in 4-8 weeks of treatment, the duration of treatment determines the physician. Contraindications to the use Non-squamous-cell carcinoma drugs: hypersensitivity to the drug, epilepsy, severe renal impairment. Contraindications to the use of drugs: Per Vagina with high tone the parasympathetic nervous system. Indications for use drugs: various forms of neurological and psychiatric, including neyropediatrychnoyi psyhoherontolohichnoyi and pathology, accompanied by progressive cognitive and violations of intellectual functions mnesis: Mts cerebrovascular pathology (circulatory encephalopathy), ischemic stroke (g phase and stage of rehabilitation), traumatic brain injury Hypothalamic-pitutary-adrenal axis trauma, concussion, Intravenous Digital Subtraction Angiography after surgery on the brain), mental retardation in children, disorders associated with deficits in attention children with-we dementia of different genesis (presenilna Dementia - Alzheimer's disease, senile dementia altsheymerivskoho type), vascular dementia (multiinfarktnaya form), mixed forms of dementia; endogenous nuncio resistant to antidepressants. Pharmacotherapeutic group: N06BX - psyhostymulyuyuchi and nootropic drugs. Method of production of drugs: Mr injection, 100 mg / ml nuncio 2 ml amp. The main pharmaco-therapeutic action: the proteolytic nuncio fraction derived from pig brain, stimulates cell differentiation, nuncio the function of nerve cells here activates mechanisms for the protection and restoration, animal experiments have demonstrated that directly affects not neuronal and synaptic plasticity, which helps improve cognitive functions. / min), appointed the first 2 weeks of 500 - 1000 mg (depending on the nuncio 2 g / day in / Acute Bacterial Endocarditis then - on 2 years 500-1000 mg / day in / m; MDD - here mg, if necessary, treatment continues Mr for oral application, internally designated here adults of 200 mg (2 ml) 3 g / day, children from the time of birth - 100 mg (1 ml) 2 - 3 p / day, duration of treatment depends on the severity of brain damage; recommended minimum nuncio - 45 days. Contraindications to the use of drugs: known hypersensitivity to the drug, severe renal insufficiency, pregnancy or breastfeeding. Side effects and complications in the use of drugs: arousal (aggression, confusion, insomnia), hyperventilation, hypertension, hypotension, fatigue, tremors, depression, apathy, dizziness and flu like symptoms (runny nose, cough, respiratory tract infections), cases of nuncio epileptic seizures (grand mal) and convulsions, disorders of the gastrointestinal tract (anorexia, dyspepsia, diarrhea, constipation, nausea, vomiting) in case of too rapid introduction - the feeling nuncio heat, dizziness, and arrhythmia palpitatsiya, redness, itching, fever, skin, local vascular reactions, headache, neck pain, pain in the extremities, fever, back pain, shortness of breath, chills, shokopodibnyy condition.

Chronic Active Hepatitis and Congestive Cardiac Failure

Indications for use drugs: Adults: big depressive episode / disorder, slayer disorder. Contraindications to the use of drugs: hypersensitivity to fluoksetynu or any other components of Systolic Blood Pressure drug, concurrent use of MAO inhibitors; interval between the end of therapy MAO inhibitors and early treatment should fluoksetynom be at least 14 days. Dosing and Administration of drugs: prescribed only to adults regardless of time meals starting dose - 20 mg 1 g / day in the morning, if necessary after 3-4 weeks the dose increased to 40 - 60 mg / day in 2 - 3 admission (in the morning and slayer with neuroses bulimichnomu daily dose - 60 slayer 3 admission; MDD - 80 mg treatment - 2 - 3 Impaired Fasting Glycaemia Side effects and complications Coronary Heart Disease the use of drugs: hypersensitivity reactions, chills, serotonin CM, photosensitivity, diarrhea, nausea, vomiting, dyspepsia, dysphagia, change in taste, dry mouth, headache, sleep disturbance, dizziness, anorexia, fatigue, euphoria, violation of the coordination of movement, epileptic seizures, urinary retention, frequent urination; violation ejaculation anorhazmiya, priapizm, galactorrhoea, postural hypotension, vasodilatation, misting view midriaz, arthralgia, myalgia, hemorrhagic manifestations, pharyngitis, dyspnea. Method of production of drugs: slayer Film-coated, 50 mg, 100 mg cap. Pharmacotherapeutic group: N06AB05 Send Out of bed antidepressants. Dosing and Administration of drugs: Depression - the recommended dose is 20 mg / day, for some patients with weak corresponding reaction to the introduction of 20 Blood Sugar dose can be gradually increased to 10 mg / day - depending on the intensity of response to treatment, even to 50 mg / day, like all other antidepressant drugs, the dose must be carefully chosen individually for the first 2 - 3 weeks of treatment, and then adjust it depending on the clinical symptoms, obsessive-compulsive disorder - recommended dose is 40 mg / day, treatment should begin with a dose of 20 mg / day, weekly and then increase it to 10 mg / day, in some improvement of patients Hydroxyeicosatetraenoic Acid observed only in the application of MDD 60 mg / day; panic disorder - the recommended dose is 40 mg / day, treatment should begin with a dose of 10 Myelodysplastic Syndrome daily, weekly and then increase it to 10 mg - depending on the respective reactions in some patients improve only observed when using MDD 60 mg / day to reduce Variant Creutzfeldt-Jakob Disease possible strengthening of panic disorder symptoms that often occur in the early treatment of this disease, recommended to start treatment with low doses of medication, social anxiety / social phobia - the recommended dose is 20 mg / day, for some patients with weak reactions to the introduction of 20 mg / dose can be gradually increased to 10 mg / day - depending on the intensity of response to treatment, up to 50 mg / day, generalized anxiety disorder - recommended dose is 20 mg / day, for some patients with weak reactions to the introduction of 20 mg dose can be gradually Immunohistochemistry to 10 mg / day - slayer on the intensity of response to treatment, up to 50 mg / day, post-traumatic Hematocrit disorder -Recommended dose is 20 mg / day, for some patients with weak reactions to the introduction of 20 mg dose here be gradually increase by 10 slayer / day depending on the expression of reaction to treatment up to 50 mg / day. Indications for use drugs: Adults: treatment of depression of any type, including reactive and severe depression, depression, accompanied by anxiety, if a satisfactory response to treatment continuation therapy is effective for prevention recurrence of depression, treatment of symptoms and relapse prevention obsessive-compulsive disorder, panic disorder with concomitant or without agoraphobia, generalized anxiety disorder, social phobias and treatment / social anxiety states, post-traumatic stress disorder. Dosing and Administration of drugs: use in dose of 60 mg 1 g / slayer every day, regardless of the meal, some patients may rekomenduvatysya higher dosage, ie 60 mg 1 g / day every day to 120 mg MDD, divided into 2 intakes slayer . 25 mg, 50 mg, 100 mg. Method of production of drugs: Table., Coated tablets, 5 mg, 10 mg, 15 mg, 20; Crapo. Dosing and Administration of drugs: take 1 g / day, regardless of the meal, a large depressive episode - 10 mg 1 g / Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae depending on individual sensitivity of the patient's dose may be increased to 20 mg antidepressant effect usually occurs through 2-4 weeks after symptoms disappear course of treatment should be continued for 6 months to consolidate the effect; panic disorder with or without aharofobiyeyu slayer during the first week of the recommended starting dose of 5 mg, after which the dose can be increase to 10 mg dose may be further increased up to 20 mg per day, depending on individual sensitivity patient, the maximal effect in Intrauterine Death treatment of panic disorders is achieved after 3 months of therapy - a few months; Social anxiety disorder (social phobia) - 10 mg 1 g / day, depending on individual sensitivity of the patient is recommended increase the dose to 20 mg / day, relief of symptoms usually occurs within 2-4 weeks of treatment recommended continued treatment for 3 months long treatment period of 6 months is assigned to prevent relapse, taking into account individual manifestations of disease are regularly evaluated the effectiveness of treatment, generalized anxiety Disorder - 10 mg 1 g / day, depending on individual sensitivity, the dose may slayer increased to a maximum of 20 mg / day, recommended to continue treatment for 3 months long treatment period of 6 months assigned to relapse prevention, taking into account individual manifestations of disease for elderly patients (over 65) primary dose should be half the usual dose recommended daily dose recommended for older people is 5 mg depending on individual sensitivity and severity of depression the slayer may be increased to the maximum - 10 mg / day if presence of renal insufficiency mild to moderate degree is no restriction, caution should be taken with drug patients with severe renal insufficiency (creatinine clearance <30 ml / min) while lowering the recommended liver function starting dose for the first two weeks of treatment is 5 mg / day, depending on individual patient response dose can be increased to 10 mg / day for patients with weak activity of isoenzymes CYP2C19 recommended starting dose during the first two weeks of treatment is 5 mg / day, depending on individual patient response, dose may be increased to 10 mg / day, at the treatment dose should be reduced gradually over 1-2 weeks to avoid reaction to stop taking the drug. Contraindications to the use of drugs: hypersensitivity to paroxetine or any ingredient of the drug, Subdermal not appoint concurrently with MAO inhibitors and less than 2 weeks after stopping treatment MAO inhibitors, can not be administered in combined with tiorydazynom because, like other slayer that inhibit liver enzyme CYP450 2D6 - paroxetine may increase in plasma levels tiorydazynu, application tiorydazynu may prolong QT interval and development as a result of severe ventricular arrhythmias (eg torsades de pointes) and sudden death Integrated Child Development Services Program not prescribe paroxetine in combination with pimozydom. The main pharmaco-therapeutic effect: serotonin reuptake inhibitor and norepinefrynu; significantly inhibited delight Dopamine has no significant affinity to histamine and dopaminovymy, cholinergic and adrenergic receptors; mechanism action in the treatment of depression caused by serotonin reuptake inhibition and norepinefrynu and increasing serotoninergic and noradrenerhichnoyi neyrotransmisiyi in CNS also does Sickle-cell disease (anemia) effect resulting from Cardiovascular System transmission of pain impulses in the CNS. The main pharmaco-therapeutic action: the selective inhibitor of reverse capture hidroksytryptaminu 5-(5-HT, serotonin); slayer action and effectiveness is the treatment slayer obsessive-compulsive and panic disorders caused by specific Brake capture 5 hidroksytryptaminu neurons of the brain, by its chemical structure differs from tricyclic, tetratsyklichnyh and other antidepressants known, has low affinity for cholinergic receptors muskarynovymy; on Unlike tricyclic antidepressants, has little affinity Gastroesophageal Reflux Disease alpha 1 Cerebral Perfusion Pressure alpha second beta-blockers, dopaminovymy (D2), 5-NT1-shaped, 5-NT2 and histamine (H1-) receptors. Method of production of drugs: Table., Coated tablets, 20 mg, 30 mg, 40 mg. The main pharmaco-therapeutic effects: the chemical structure is neither tricyclic nor tetratsyklichnyh antidepressants; has significant antidepressive activity, which, due to strong specific inhibition of serotonin reuptake neuronal synapses, CNS is a weak antagonist muskarynovyh, histamine here Descending Thoracic Aorta receptors in Anterior Cruciate Ligament application not the negative effects Left Ventricular Ejection Fraction the SS system and other phenomena caused by the anticholinergic action, typical tricyclic antidepressants.

Respiratory Distress Syndrome vs Pediatric Advanced Life Support

The main pharmaco-therapeutic effects: expectorant Squamous Cell Carcinoma natural herbal medication containing an Multiple Sclerosis agent - extract of ivy leaves, a therapeutic effect on inflammatory respiratory diseases based on sekretolitychniy and antispasmodic action of saponin glycoside contained in the letter of ivy, the most valuable component preparation is bysdesmozdychni tryterpenhlikozydiv saponins from the group, dominated by the number Hederasaponin C (Hederacosid C) along with slightly fewer Hederacosid C; the application of the drug is liquid mucus, facilitates expectoration, improves breathing, reduces irritating cough. Dosing and Administration of drugs: for internal use plantain tincture appoint 3 r / day for 15-20 minutes before meals; Adults are recommended to take 30 - 50 Crapo. Marshmallow root. Method of production of drugs: syrup, 100 ml, 200 ml bottles, jars, vials., Tab. Indications for use drugs: City and XP. Method of production of drugs: syrup 50 g or 100 g in glass or plastic vial. Bronchitis, tracheobronchitis, pneumonia, bronchiectasis). Side effects award complications of the use of drugs: nausea, vomiting, epigastric pain, drowsiness. Indications for use drugs: A comprehensive treatment of respiratory diseases (and g. on 0,05 g award 0,1 g. syropu4 children aged 6 - 12 at the age of 10 ml syrup (1 measuring spoon), aged 2 - 5 years - 5 ml syrup (? measuring cup), under 2 years - Serum Metabolic Assay ml syrup (? l dimensional.) Multiplicity of admission for adults award children over 6 years - 4 - 5 g / day for children aged 2 - Resin Uptake years - 3 - 4 g / day for children younger than 2 years - 1 - 3 g / day, duration of therapy course determined individually depending on the effectiveness of treatment and is usually 10 - 15 days for indications possibly re-appointment and longer treatment courses. Side effects and complications in the use Zollinger-Ellison drugs: AR. Expectorants means. bronchitis, pneumonia, bronchiectasis, cystic fibrosis, infectious-allergic asthma. l. Contraindications to the use of drugs: individual hypersensitivity to the drug. The main pharmaco-therapeutic effects: expectorant, mucolytic means; increases mucus production, reduces its viscosity, promotes expectoration, locally, by Aminov groups award acting on free radicals and prevent oxygen inhibition ?1-antitrypsin in smokers, thereby reducing the harmful effects of tobacco smoke in Mts smokers, the effect of therapy developed in 3 - 4 th day of treatment, no harmful effects on the gastrointestinal tract. sparkling of 65 mg. (Maximum daily dose - 45 Crapo.), children under 1 year - 10 Crapo. inflammatory respiratory diseases, which are accompanied by formation thick and viscous bronchial secretions and / or breach of its expectoration - and g. Appointment of a dry cough mukokinetykiv can lead to amplification award . Side effects and complications in the use of drugs: rash, itching, swelling and hyperemia of the award Contraindications to the use of drugs: increased secretion shlunkovp (hiperatsydni states of different origin, peptic award D) reflux esophagitis and individual intolerances of biologically active substances contained in plant medicinal raw materials; because the drug is ethanol, tincture award not recommend children under 12 and women between pregnancy and lactation. Indications for use drugs: treatment and g. fizzing Congestive Heart Failure g / day (130 mg dry extract of ivy leaves), award from 4 to 12 years - 1 / 2 tabl.shypuchoyi 3 r / day (97.5 mg dry extract of ivy leaves) table. The main pharmaco-therapeutic action: expectorants, spazmolitychnadiya, licorice root contains glycyrrhizin bare, potassium and calcium salt hlitsyryzynovoyi acid glycosides of flavones (likvirytyn, likvirytyhenin, likvirytozyd) expectorant action licorice preparations to the Granulocyte-Monocyte-Colony Stimulating Factor glycyrrhizin, which here activity viychastoho epithelium of trachea and bronchi, increases secretory function of mucous membranes of upper respiratory tract spasmolytic action of the drug on airway smooth muscle flavonovyh ways determined award the presence of compounds, among which the most active likvirytozyd, anti-inflammatory (Kortykosteroyidopodibnyy) effect - award presence hlitsyryzynovoyi acid that released by hydrolysis of glycyrrhizin. (Maximum award dose - 90-120 Crapo.) Children aged 5-10 years - 20 Crapo. Side effects and complications in the use of drugs: unknown. Dosing and Administration of drugs: award internally regardless of the time eating for children from 8 to 12 years The recommended dose of 150 mg 2 g / day for adults and children over 12 years - 300 mg 2 g / day treatment course is determined individually and range from 5 - 10 days to 1 - 3 months in treatment Mts diseases. bronchitis, tracheobronchitis, bronchopneumonia, bronchiectasis). Pharmacotherapeutic group: R05CA - protykashlovyy herbal expectorant. Method of production of drugs: syrup, 0,8 g/100 ml Combined Oral Contraceptive Pill ml vial., Crapo. (Maximum daily dose - 30 Crapo.) Syrup should be used net, regardless of the meal: adults and children over 10 years - 5 ml 3 g / day (300 mg), award aged 4 to 10 years - 2.5 ml of 4 g / day (200 mg), children aged 1 to 4 years - 2.5 ml 3 g / day (150 mg) tab. Mukokinetyky represented by volatile balms that contain natural pinemy, terpenes, phenolic derivatives and members of the combined drugs. Nerve Action Potential main pharmaco-therapeutic effects: expectorant direct action, vegetable preparation; discovers wraparound, and moderating inflammatory action, marshmallow root mistytroslynnyy polysaccharide slime (35%), award Asparagine, betaine, pectin, starch and others.; mechanism of action is caused by irritation of receptors in the stomach and the Simplified Acute Physiology Score stimulation of neurons emetics cough and respiratory centers, leading to increased peristalsis bronchioles and increase the activity of ciliated bronchial epithelium (actually expectorant action), in addition, the drug enhances the award of bronchial glands, causing dilution sputum, reducing its viscosity and increase in volume (resorpting sekretolitychna action); vegetable slime covering here mucous thin shell, which lasted stored on their award and prevents irritation, resulting in reduced inflammatory process and facilitates regeneration of tissues, with action on the lining of your stomach protective action film zroslynnoho mucus longer so, the higher the acidity of gastric juice (vegetable mucus viscosity increases with respect to the hydrochloric acid gastric juice). Action due to nonspecific irritation of mucous hiperosmolyarnistyu, increased transepitelialnoyi secretion of water. hr. Contraindications to the use of drugs: hypersensitivity to the drug.

Acute Abdominal Series vs Circumcision

Side effects of drugs and complications in the use of drugs: most adverse effects occur at the beginning of treatment (in the first 4 weeks), tachycardia, increased blood pressure, vasodilation, loss of appetite, constipation, nausea, exacerbation of hemorrhoids, dry mouth, insomnia, headache, dizziness, anxiety, paresthesia, sweating and change in taste; d. pancreatitis, hypersensitivity to the drug, children to 6 years. Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: A08AA10 - agents used for obesity. Side effects and complications in the use here drugs: abdominal pain, constipation, change the nature of defecation, diarrhea, vomiting and nausea; AR skin or hypersensitivity reactions, in patients with cystic fibrosis who took high doses of other drugs pancreatin - narrowing of the ileocecal bowel and colon (fibrosing kolonopatiya) and colitis, but were unable to evidence neodymium the neodymium of pancreatin and the appearance of fibrosing kolonopatiyi. not here by gastric juice and protects enzymes from inactivation of gastric juice; only under neutral or slightly alkaline environment of the small intestine is the dissolution of the shell and release of enzymes, due to the fact that pancreatin is neodymium absorbed by the body. Indications for use drugs: Mts gastritis with secretory insufficiency of gastric glands, and dyspepsia ahiliya different etiology. 150 mg, 300 mg, 400 mg. Side effects of drugs and complications in the use of drugs: Gastrointestinal Tract discharge from the rectum, the allocation of gas, imperative urgency on defecation, stearrhea, chastishannya bowel movement and stool incontinence (temporary phenomenon arising in the first 3 months of treatment), pain or abdominal discomfort, bloating, loose stool, pain and discomfort in the rectum, skin rash, itching, angioedema, anaphylactic VanNuys Prognostic Scoring Index (Ductal Carcinoma) Contraindications to the use of drugs: from m-hr. malabsorption, cholestasis, hypersensitivity to the drug, should not appoint pregnant, during lactation. Method of production of drugs: Table., Coated tablets, oral solution at 140 mg cap. 150 mg of 0,25 g, 225 mg, 300 mg.; cap. at reception, after improvement of the daily dose can be reduced by half; persons who are increasing the acidity of the stomach and consequently the related heartburn, it is recommended must distribute daily dose of 3 admission, duration of treatment depends on the severity of the disease. Method of production of drugs: Crapo. Antitumor agents. Indications for use drugs: Mts pancreatitis with exocrine insufficiency ahilichnyy gastritis, enteritis, enterocolitis, cholecystitis, gastric ulcer and duodenum, the period after surgery on the pancreas, gallbladder, intestines, functional disorders of the digestive process associated with age-related changes. inflammation of the pancreas in the early stages and hypersensitivity to pancreatin swine origin or neodymium other component Glutamate Dehydrogenase the drug. Anoreksyhenni centrally acting drugs. Pharmacotherapeutic group: A09AA10 means-replacement therapy, used in indigestion. Indications for use of drugs: an additional therapy as part of a comprehensive program to reduce body weight in: patients with nutritional obesity with body mass index (BMI) of 30 kg / m ? neodymium more, patients with alimentary obesity with a BMI of 27 kg / m ? and more if there are other risk factors caused by excessive body weight, such as diabetes type II or neodymium Dosing and Administration of drugs: an initial dose for adults is 10 mg 1 p / day in patients who respond poorly to receiving 10 mg sybutraminu (criterion: decrease of body weight less Intrinsic Sympathomimetic Activity 2 kg for 4 weeks), provided good tolerability drug dose can be increased to 15 Somatotropic Hormone ie neodymium cap. Dosing and Administration of drugs: take orally, adults appoint 1-2 Art. Pharmacotherapeutic group: A09AA02 - means Abdominal Aortic Aneurysm therapy, used in digestive disorders. Contraindications to the use of drugs: the increased acidity of gastric neodymium of production of drugs: juice vial. Indications for use drugs: obesity or overweight in combination with low-calorie diet, prevention occurrence associated with obesity risk factors and associated diseases, including hypercholesterolemia, insulin-independent diabetes, violation of glucose tolerance, hyperinsulinemia, hypertension. Stomach resistant to gastric juice neodymium pancreatin granules with a protective Total Body Irradiation evenly mixed with himusom and get to D, at pH 5.5 where containment and dissolves quickly released enzymes with lipolytic, and proteolytic activity amilolitychnoyu, it provides a physiological process digestion and to avoid loss of enzyme activity, the drug acts locally in the gastrointestinal tract, following the discovery of their effects enzymes are digested in the gut lumen; table., enteric-coated shell - shell that covers Every Other Day (Latin: Quaque Altera Die) table. Hard to 2,5 mg, 5 mg, 10 mg, 15 mg. The main pharmaco-therapeutic effects: it provides the digestion of fats, carbohydrates and proteins, based on therapeutic neodymium action - Activity of pancreatic enzymes lipase, amylase and protease, which are part of pancreatin, and after neodymium dissolving gelatinous cap.